AstraZeneca antibody treatment reduces severe COVID-19 cases: study | TheHill – The Hill
Optimistic news emerged from AstraZeneca on Friday, with new clinical data suggesting its COVID-19 antibody drug saw a significant reduction in severe symptomatic COVID-19 infections among recipients.
Observed in Phase three clinical trials, results saw…
